The concept of Vmn2r85 Inhibitors encompasses a diverse array of compounds that, while not directly targeting Vmn2r85, possess the capability to modulate signaling pathways and cellular processes indirectly related to the function of Vmn2r85. This receptor, part of the vomeronasal system, plays a crucial role in pheromone detection and signaling, a process that involves complex intracellular pathways typical of GPCRs. Given the absence of direct inhibitors, the strategy employed focuses on altering the broader signaling landscape within which Vmn2r85 operates. By targeting key regulatory molecules and pathways-such as those involved in cAMP production, calcium signaling, and various kinase activities-these inhibitors can alter the cellular context and modulate the receptor's function. This approach not only provides a means to explore the biological functions of Vmn2r85 but also highlights the intricate web of cellular signaling pathways that govern sensory perception and response mechanisms at the molecular level.
Through this exploration, the selected compounds serve as tools for investigating the physiological roles of Vmn2r85 and the mechanisms by which it contributes to pheromone detection and signaling. This strategy underscores the complexity of signaling networks and the nuanced approaches required to influence receptor activity indirectly. The strategic selection of these compounds offers a foundation for probing the signaling pathways and processes underpinning Vmn2r85's function, facilitating a deeper understanding of the molecular underpinnings of sensory signaling. This methodology exemplifies the broader principles of signal transduction and cellular communication, emphasizing the potential of targeted chemical intervention to unravel the signaling dynamics of specialized receptors such as Vmn2r85, providing insights into the dynamic interplay of signals that drive cellular responses and behaviors.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
KN-93 | 139298-40-1 | sc-202199 | 1 mg | $182.00 | 25 | |
Inhibits CaMKII, potentially affecting calcium signaling pathways linked to Vmn2r85 function. | ||||||
Xestospongin C | 88903-69-9 | sc-201505 | 50 µg | $510.00 | 14 | |
IP3 receptor inhibitor, potentially disrupting calcium signaling pathways associated with Vmn2r85. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
MEK inhibitor, could affect MAPK/ERK pathways potentially related to Vmn2r85 signaling. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
PI3K inhibitor, could modulate AKT signaling pathways relevant to Vmn2r85 function. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
Src kinase inhibitor, potentially disrupting kinase-mediated signaling cascades relevant to Vmn2r85. | ||||||
Gö 6983 | 133053-19-7 | sc-203432 sc-203432A sc-203432B | 1 mg 5 mg 10 mg | $105.00 $299.00 $474.00 | 15 | |
PKC inhibitor, could affect signaling pathways that intersect with Vmn2r85's function. | ||||||
BAPTA/AM | 126150-97-8 | sc-202488 sc-202488A | 25 mg 100 mg | $138.00 $458.00 | 61 | |
Calcium chelator, could disrupt intracellular calcium signaling associated with Vmn2r85. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
p38 MAPK inhibitor, potentially affecting stress response pathways related to Vmn2r85. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Another PI3K inhibitor, reinforcing the blockade of pathways potentially affecting Vmn2r85. | ||||||